Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands

Journal of Medical Screening

Volumn 5, Issue 1, 1998, Pages 37-41

  Schouten, Leo J ^a   De Rijke, J Marjan ^a,b   Schlangen, Johan Th ^c   Verbeek, André L M ^b,d  

^a Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c LAURENTIUS HOSPITAL   (Netherlands)

^d Department of Epidemiology ^*

Author keywords

Breast cancer; Cancer registry; Evaluation studies; Interval cancers; Netherlands

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS;

EID: 0031745566     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.5.1.37     Document Type: Article

References (23)

1. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents. Vol VI. Lyon: International Agency for Research on Cancer, 1992. (IARC Scientific Publications No 120.)
2. De Winter GA, Coebergh JWW, Van Leeuwen FE, Schouten LJ, eds. Incidence of cancer in the Netherlands 1989. First report of the Netherlands Cancer Registry. Utrecht: Landelijk Overlegorgaan integrale Kankercentra, 1992.
3. De Koning HJ, Fracheboud J, Boer R, et al. Nation-wide breast cancer screening in the Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer (NETB). Int J Cancer 1995;60: 777-80.
4. National Evaluation Team for Breast Cancer Screening. National evaluation of breast cancer screening in the Netherlands (V). Rotterdam: Erasmus University, 1996. (In Dutch.)
5. Day NE, Williams DRR, Kwah KJ. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-8.
6. Verbeek ALM, Van den Ban AC, Hendriks JHCL. A proposal for short-term quality control in breast cancer screening. Br J Cancer 1991;63:261-4.
7. Tabar L, Faberberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987;55:547-51.
8. Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 1989;59:929-32.
9. Brekelmans C. Natural history and epidemiology of interval breast cancer in the DOM screening programme. University of Utrecht, 1995. (PhD thesis.)
10. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P. Is the three year breast cancer screening interval too long? Occurrence of interval cancers in NHS breast cancer screening programme's north western region. BMJ 1995; 310:224-6.
11. Field S, Michell MJ, Wallis MGW, Wilson ARM. What should be done about interval breast cancers (editorial). BMJ 1995;310:203-4.
12. Day N, McCann J, Camilleri-Ferrante C, et al. Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screening 1995;2:180-5.
13. Schouten LJ, Van den Brandt PA, Jager JJ. Cancer incidence in the province of Limburg, the Netherlands. Eur J Cancer 1992;28A:1752-5.
14. International Union Against Cancer. TNM. Classification of malignant tumours. 4th ed. Berlin: Springer, 1987.
15. Schouten LJ, Höppener P, Van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, the Netherlands. Int J Epidemiol 1993;22:369-76.
16. Schouten LJ, Straatman H, Kiemeney LALM, Gimbrère CHF, Verbeek ALM. The capture-recapture method for estimation of cancer registry completeness: a useful tool? Int J Epidemiol 1994;23:1111-16.
17. Van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, Hünen PMH. Development of a record linkage procedure for use in the Dutch cancer registry for epidemiologic research. Int J Epidemiol 1990;19:553-8.
18. Miettinen OS. Components of the crude risk ratio. Am J Epidemiol 1972;96:168-72.
19. Otten JDM, Van Dijck JAAM, Peer PGM, et al. Long term breast cancer screening in Nijmegen, the Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 1996;50:353-8.
20. Threlfall AG, Woodman CBJ, Prior P. Breast cancer screening programme: should the interval between tests depend on age? Lancet 1997;349:472.
21. Schouten LJ, De Rijke JM, Schlangen JT, Verbeek ALM. Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 1997;349:1104.
22. Prior P, Woodman CBJ, Wilson S, Threlfall AG. Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screening 1996;3:119-22.
23. Coebergh JWW, Van der Heijden LH, Janssen-Heijnen MLG, eds. Cancer incidence and survival in the southeast of the Netherlands 1955-1994: a report from the Eindhoven Cancer Registry. Eindhoven: Integraal Kankercentrum Zuid, 1996.